Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Phoenix | 8,236 Studies Near You

Clinical TrialsPhoenix

Clinical Trials in Phoenix

Discover 8,236 clinical trials near Phoenix, Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 701-720 of 8,236 trials

CompletedEffect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)The primary objective is to determine the efficacy of AMR101 (ethyl icosapentate) compared to placebo in lowering high fasting triglyceride levels in patients with high risk for…NCT01047501·Muscle Shoals, Alabama and 79 others

Find Trials by Condition in Phoenix

Breast Cancerin Phoenix Lung Cancerin Phoenix Prostate Cancerin Phoenix Colorectal Cancerin Phoenix Melanomain Phoenix Leukemiain Phoenix Lymphomain Phoenix Pancreatic Cancerin Phoenix Ovarian Cancerin Phoenix Brain Cancerin Phoenix Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingA Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell MalignanciesThis is a Phase I/II, multicenter, open-label study to evaluate the safety, efficacy, tolerability, and pharmacokinetics of a novel BTK inhibitor, Orelabrutinib (ICP-022) in…NCT04014205·Phoenix, Arizona and 35 others

Active not recruitingEfficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainThe primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a…NCT06325566·Phoenix, Arizona and 39 others

CompletedClinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.Complicated urinary tract infections (cUTIs) often lead to the overuse of empiric antibiotics, risking inappropriate treatment and contributing to antimicrobial resistance.NCT06996301·San Jose, California and 5 others

CompletedStudy to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo TabletsThe primary purpose of this study is to assess the acceptability of swallowing the darunavir/cobicistat (DRV/COBI) and darunavir/cobicistat/emtricitabine/tenofovir alafenamide…NCT02993237·Phoenix, Arizona and 3 others

RecruitingRadiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryThis phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who…NCT02734537·Birmingham, Alabama and 678 others

CompletedFirst-in-human Single Ascending Dose Study of LNA043 in Patients Scheduled for Total Knee ReplacementThis study is designed to evaluate the safety and tolerability of ascending single doses of LNA043 given intra-articularly into the human knee joint prior to its removal at total…NCT02491281·Phoenix, Arizona

TerminatedTRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian CancerThe purpose of this study is to determine whether AMG 386 or AMG 386 Placebo in combination with Paclitaxel and Carboplatin are effective in the treatment of ovarian cancer.NCT01493505·Birmingham, Alabama and 309 others

No longer availableExpanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative TherapyAn expanded access/compassionate use protocol that allows access to Mylotarg for relapsed/refractory AML CD33 positive patients in the USA. Contact: B1761026@iconplc.comNCT02312037·Birmingham, Alabama and 141 others

CompletedAsthma Disparities in Latino Children:Acculturation,Illness Representations & CAMThis interdisciplinary multi-level study moves the research in asthma health disparities from descriptive studies of individual constructs and contexts to testing an integrated…NCT01099800·Phoenix, Arizona and 3 others

TerminatedG-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)This is a long-term safety follow-up study to assess the post-treatment safety, at 12 and 24 months, in patients with type 2 diabetes after participation in the phaseII/III…NCT00255645·Birmingham, Alabama and 542 others

CompletedFlibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal WomenThe objective of this trial is to assess the safety and efficacy of 24-week course of flibanserin for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in naturally…NCT00996372·Birmingham, Alabama and 74 others

CompletedStudy to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)The purpose of this study is to determine the effects of different doses of methotrexate (MTX) when taken with adalimumab in subjects with early rheumatoid arthritis (RA).NCT01185301·Huntsville, Alabama and 67 others

AvailableExpanded Access Protocol (EAP) for Nonconforming (NC) Afami-celThe purpose of this expanded access protocol (EAP) is to provide controlled access to Afamitresgene autoleucel, suspension for intravenous infusion that does not meet the…NCT06617572·Phoenix, Arizona and 10 others

CompletedStudy to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement SurgeryThe objectives of this study are to evaluate the safety and analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection in patients undergoing…NCT02807428·Birmingham, Alabama and 8 others

CompletedA 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-CThis phase 3, 12-week, randomized, double-blind, placebo-controlled, multi-center study will evaluate the safety and efficacy of tenapanor in subjects with…NCT02621892·Birmingham, Alabama and 110 others

CompletedThe MitraClip® EXPAND Study of the Next Generation of MitraClip® DevicesThe MitraClip EXPAND Study (A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip Devices) is designed…NCT03502811·Birmingham, Alabama and 56 others

Active not recruitingStudy to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.NCT06958211·Birmingham, Alabama and 106 others

RecruitingA Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque PsoriasisThe purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasisNCT06979453·Birmingham, Alabama and 131 others

CompletedOpen-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)This is a multi-center, open-label, 52-week safety and tolerability study of plecanatide in patients with Chronic Idiopathic Constipation (CIC).NCT01919697·Birmingham, Alabama and 219 others

PreviousPage 36 of 412Next

in Phoenix

Heart Diseasein Phoenix